Cargando…
Kaposiform lymphangiomatosis effectively treated with MEK inhibition
Kaposiform lymphangiomatosis (KLA) is a rare lymphatic anomaly primarily affecting the mediastinum with high mortality rate. We present a patient with KLA and significant disease burden harboring a somatic point mutation in the Casitas B lineage lymphoma (CBL) gene. She was treated with MEK inhibiti...
Autores principales: | Foster, Jessica B, Li, Dong, March, Michael E, Sheppard, Sarah E, Adams, Denise M, Hakonarson, Hakon, Dori, Yoav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539180/ https://www.ncbi.nlm.nih.gov/pubmed/32894644 http://dx.doi.org/10.15252/emmm.202012324 |
Ejemplares similares
-
Treatment of severe Kaposiform Lymphangiomatosis positive for NRAS mutation by MEK-inhibition
por: Chowers, Guy, et al.
Publicado: (2022) -
Kaposiform lymphangiomatosis and kaposiform hemangioendothelioma: similarities and differences
por: Ji, Yi, et al.
Publicado: (2019) -
Sirolimus in the treatment of kaposiform lymphangiomatosis
por: Zhou, Jiangyuan, et al.
Publicado: (2021) -
Refractory kaposiform lymphangiomatosis relieved by splenectomy
por: Lan, Yuru, et al.
Publicado: (2023) -
A Somatic Activating NRAS Variant Associated with Kaposiform Lymphangiomatosis
por: Barclay, Sarah F., et al.
Publicado: (2018)